International binding agreements oblige signatories, including Ireland, to reduce their use of mercury to protect the environment. In response, the Irish Government need to phase out the use of dental amalgam by 2030. The aim of this evidence review was to examine factors relevant to phasing out amalgam and consider alternative replacement strategies for treating […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This report presents findings from the tenth national psychiatric census of patients in psychiatric units and hospitals, the latest in a series of censuses first carried out in 1963. The census is a count of all patients resident in psychiatric units and hospitals operating within the provisions of the Mental Health Act 2001, (Government of […]
Outputs, outcomes and emerging impacts: Results from HRB awards completed in 2016/2017 This report presents a snapshot of, and provides trend analysis over 10 years for, the outputs, outcomes and some emerging impacts from 187 HRB awards (combined value of €47.2 million) that completed in 2016 and 2017. It demonstrates that HRB-funded researchers are highly […]
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among people who use drugs which are not due to poisoning (non-poisonings) for the period 2008-2017.
Since 2004, the HRB has invested €37.9 million to support the development of leaders in research in both the academic and clinical environments through the Research Leader Awards in Population Health and Health Services Research (RLA in PHHSR) and the Clinician Scientist Awards (CSA). This evaluation was conducted by the HRB to determine whether these […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. It covers the period 2012 to 2018. In this seven-year period, 54,263 cases were treated for alcohol as a main problem drug.
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2012 to 2018. In this seven-year period, 65,216 cases were treated for drug use as a main problem.
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This report presents the outcomes of a review of HRB’s investment in clinical research infrastructures in Ireland conducted in 2018. The aim of the review was to generate appropriate evidence on current strengths, synergies, gaps, duplications and needs in Ireland’s clinical research infrastructures, either those funded directly or peripherally by the HRB, in order to […]
Inadequate community supports and deficiencies in access to services outside of regular office hours have been linked to poor outcomes for patients with life-limiting illness. Policy-makers, researchers, providers, patients, and carers in Ireland have all identified out-of-hours care as a key deficit in current service provision. The Department of Health commissioned this review to inform […]
Contents include: Chairperson and Chief Executive’s report; Snapshot of HRB activities during 2018; Key deliverables in line with HRB strategy 2016 – 2020; and Appendices. The Corporate Governance and Financial Statements were published in a Part 2 on 14 January 2020 following approval of the financial statements by the Office of the Comptroller and Auditor […]
The scope of this rapid realist review was developed through a high-level review of relevant literature and early engagement of knowledge users in Ireland. The Health Research Board (HRB) proposed three research questions to guide the rapid realist review. Keeping in line with the realist approach, the research team carried out a process to refine […]
The aim of this review of vaccine injury redress programmes in 11 jurisdictions was to investigate the association between design features of the programmes and operating costs, timely access to compensation, number of applicants, and the volume and costs of awards. The databases MEDLINE, CINAHL, Scopus, Web of Science, Cochrane Library, HeinOnline, and LegalTrac were […]
The 2018 report provides data presented nationally as well as: * CHO * county * hospital type * individual psychiatric units/hospitals
In Europe, many people with intellectual disabilities continue to live in congregated settings. In 2012, Ireland formally introduced a resettlement policy with people moving to live in more personalised arrangements. This longitudinal country case-study aimed to monitor the implementation of this policy and the intra-country variations that arose using the records maintained in the National […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2011 to 2017. In this seven-year period, 63,303 cases were treated for drug use as a main problem.
This information review, undertaken on behalf of the Department of Health, informs the National Healthy Workplace Framework and implementation plan and will contribute to the business case for healthy workplace programmes. Five anglophone countries (Australia, Canada, New Zealand, Scotland and the USA) were included in the review. This information review found that in each of […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. It covers the period 2011 to 2017. In this seven-year period 55,675 cases were treated for alcohol as a main problem drug. The number of cases treated has fallen slightly in recent […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This update presents figures from the National Drug-Related Deaths Index (NDRDI) on deaths due to poisoning (overdose) by alcohol and/or other drugs, and deaths among people who use drugs which are not due to poisoning (non-poisonings) for the period 2004-2016.
Many studies show that incarcerated populations have higher rates of problem drug use than the general population. The purpose of this paper is to analyse trends in addiction treatment demand in prisons in Ireland from 2009 to 2014 using available national surveillance data in order to identify any implications for practice and policy.